#SAVETHEDATE On Oct 7 - 8 will be held the #HTID7!.This event aims to foster new industrial partnerships & investments in #biotechs to accelerate the development & accessibility to new treatments for #patients. Let's connect and collaborate to the evolution of #healthcare. 📅

👋 The #ESCCongress is coming! We look forward to meeting you at our booth – No. E300 – for “As One Experience”, a unique journey to showcase our expertise, and during the 3 symposiums held by Servier.#hypertension #angina #HeartFailure #cardiology #AsOne @escardio

💪 At Servier, we prioritize quality of life by fostering inclusivity, work-life balance, and hybrid work. Our efforts pay off: employee engagement rose from 3.91 (2019) to 4.35/5 (2025), with 86% recommending us as a great workplace. ✨ Proud to receive the 2025 @Gallup

Aligned with our values, Mécénat Servier fosters social innovation through lasting partnerships and support. Since 2016, it has:.📌 Supported 56 nonprofits in 32 countries.📌 Focused on 5 areas: health, education, culture, living together, humanitarian aid.📌 Engaged 6,900

🌍 A healthy environment is essential for good health. At Servier, we believe that protecting our planet means protecting the health of all. 🎯 By 2030, we aim to reduce CO2 emissions by 42% (scopes 1 & 2) and 25% (scope 3) vs. 2021-2022. We embed sustainability across our

At Servier, we stand by organizations making difference in:.🩺 Health.🎭 Culture .📚 Education .🏘️ Living Together.🕊️ Humanitarian actions. Learn more about our commitments and our partners at 👉 #WeAreServier #WorldHumanitarianDay #Solidarity

Humanitarian aid is not just about emergency relief, it’s also restoring dignity, protecting rights and unlocking resilience. These actions can take several forms:. 👶 A child receiving life-changing surgery with "Face au Monde".💄 A woman facing cancer, regaining confidence with

❗️According to the United Nations, in 2025, 305 million people need urgent humanitarian aid due to escalating crises. Today, on World Humanitarian Day, we honor those who act every day to support those who need it most. 🌍. Learn more about our commitments and our partners at 👉

👋 At Servier, our mission to serve patients drives us to expand where healthcare needs are greatest. Our medicines reach close to 140 countries 🌎. In 2023/2024, our 14 production sites made 530 million boxes of brand-name medicines. We produce 95.9% of active ingredients in

Aligned with our #Servier2030 ambition, we’re dedicated to working with patients every day. As patients take more control of their health, we partner with them to develop medicines that truly meet their needs. In 2023/24, we collaborated with 140 patient organizations to ensure

As part of our #Servier2030 ambition, we’re expanding R&D to neurology, focusing on refractory epilepsy, rare movement disorders, and neuromuscular diseases. 🧠🔬. We’re investing heavily to develop drugs that slow disease progression or ease symptoms. 💊 Our pipeline currently

🌍 As a global leader in hypertension and venous diseases, and a key player in cardiometabolism, we drive innovation to improve patients’ lives through a holistic approach focused on adherence and control. We develop incremental innovations like Single Pill Combinations 💊 and

Why join Servier as an intern, apprentice or V.I.E?.✅ A meaningful mission in healthcare.✅ Real responsibilities, from day one.✅ Mentorship and international exposure.✅ A collaborative, people-first culture. At Servier, young talents don’t just learn; they grow, contribute,

🌍 On this International Youth Day, at Servier we highlight the essential role young talents play across every stage of the medicine lifecycle. At Servier, interns, apprentices and V.I.E.s contribute to:.🔬 early research and clinical development.🏭 industrial operations and

🎗️ At Servier, we have been committed to fighting cancer for many years. Oncology is a major therapeutic priority for us, accounting for close to 70% of our R&D investments. 💊 A portfolio of 8 medicines available to healthcare professionals and patients. 🔬 A robust pipeline

Our promising R&D pipeline — focused mainly on oncology and now neurology — includes 36 projects in clinical development and 24 research projects resulting from significant and continuous R&D investment. 🔬. To date, 50% of the Group's research projects have the potential to

🌍 Founded to serve health, at Servier, we aspire to create meaningful social impact for patients and contribute to a sustainable world. 🌱. Our unique governance — led by the non-profit foundation — allows us to reinvest close to 20% of revenue from brand-name medicines in R&D

🌟 Over 22,000 employees committed to therapeutic progress to serve patient needs!. At Servier, our medicines are distributed in close to 140 countries worldwide 🌐. 530 million boxes of brand-name medicines were produced in 2023-2024 through our 🏭 network of 14 production

🌟 70 years of innovation & commitment to therapeutic progress to serve patient needs! . This milestone reflects not only our journey but also the incredible talent and commitment of our 22,000 employees around the globe 🌍. 86% of our employees recommend Servier as a great place

🧪Antibody-drug conjugates (ADCs) combine the precision of antibodies with the power of traditional medicine. They work like guided missiles: the antibody finds the diseased cell, and the drug is released exactly where it’s needed inside the cell. 🧠 It’s a promising.